Calluna Pharma, a clinical stage company pioneering a breakthrough approach to treating inflammatory and fibrotic diseases, has appointed Margrethe Sørgaard to the position of Senior Vice President (VP) of Clinical Operations and Pharmacovigilance.   Sørgaard joins the company’s cross-functional R&D team following Calluna’s launch, to oversee the strategic development of the company’s clinical programs in line with regulatory guidelines and safety requirements.      Of note, Sørgaard wil...